AHL Partners’s CONMED CNMD Stock Holding History

AHL Partners’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$6.75M	Buy	132,488 +3,662	+3%	+$191K	0.11%	374
2017 Q3	$6.76M	Sell	128,826 -29,264	-19%	-$1.47M	0.12%	305
2017 Q2	$8.05M	Buy	158,090 +152,624	+2,792%	+$7.55M	0.17%	174
2017 Q1	$242K	Buy	+5,466	New	+$235K	0.01%	1120
2016 Q2	–	Sell	-7,636	Closed	-$320K	–	832
2016 Q1	$320K	Sell	7,636 -77,421	-91%	-$3.04M	0.02%	659
2015 Q4	$3.75M	Buy	85,057 +48,996	+136%	+$2.13M	0.29%	131
2015 Q3	$1.72M	Sell	36,061 -54,241	-60%	-$2.98M	0.27%	118
2015 Q2	$5.26M	Buy	+90,302	New	+$4.87M	0.21%	155

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AHL Partners's CNMD Position: Q4 2017 in Review

AHL Partners increased its CONMED (CNMD) stake by 2.8% in Q4 2017, buying an estimated $191K and bringing the position to 132,488 shares worth $6.75M. The position accounts for 0.11% of the portfolio, ranked #374.

AHL Partners first reported a position in CNMD in Q2 2015 and has held it in 8 quarters since. The position peaked at $8.05M in Q2 2017. 160 funds tracked by Wall St. Rank hold CNMD as of Q4 2017.

AHL Partners held 132,488 shares of CONMED worth $6.75M as of Q4 2017.
AHL Partners bought 3,662 CONMED shares in Q4 2017, an estimated $191K.
CONMED made up 0.11% of AHL Partners's portfolio in Q4 2017, its #374 holding.
AHL Partners first reported a position in CONMED in Q2 2015 and has held it in 8 quarters since.
AHL Partners's CONMED position peaked at $8.05M in Q2 2017.
160 funds tracked by Wall St. Rank held CONMED as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.